Assenagon Asset Management S.A. lessened its stake in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 30.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,500 shares of the biopharmaceutical company’s stock after selling 7,379 shares during the quarter. Assenagon Asset Management S.A. […]
